SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 9, 2026 OWNERSHIP DOCUMENT
4 Jan 9, 2026 OWNERSHIP DOCUMENT
4 Jan 9, 2026 OWNERSHIP DOCUMENT
4 Jan 9, 2026 OWNERSHIP DOCUMENT
4 Jan 9, 2026 OWNERSHIP DOCUMENT
8-K Jan 8, 2026 FORM 8-K
4 Dec 5, 2025 OWNERSHIP DOCUMENT
4 Dec 5, 2025 OWNERSHIP DOCUMENT
4 Dec 5, 2025 OWNERSHIP DOCUMENT
EFFECT Nov 25, 2025
CORRESP Nov 21, 2025
4 Nov 21, 2025 OWNERSHIP DOCUMENT
SCHEDULE 13G Nov 14, 2025
8-K Nov 12, 2025 8-K
10-Q Nov 12, 2025 10-Q
424B5 Oct 27, 2025 424B5
8-K Oct 27, 2025 FORM 8-K
SCHEDULE 13G Oct 17, 2025
S-3 Oct 10, 2025 FORM S-3
8-K Oct 3, 2025 FORM 8-K
8-K Sep 11, 2025 FORM 8-K
SCHEDULE 13G/A Aug 14, 2025
S-8 Aug 12, 2025 FORM S-8
8-K Aug 12, 2025 8-K
10-Q Aug 12, 2025 10-Q
← Newer Page 2 of 51 · 1272 filings Older →